TY - JOUR
T1 - Collecting clinical data in primary ciliary dyskinesia- challenges and opportunities [version 1; referees
T2 - 2 approved]
AU - Amirav, Israel
AU - Roberts, Mary Roduta
AU - Mussaffi, Huda
AU - Mandelberg, Avigdor
AU - Roth, Yehudah
AU - Abitbul, Revital
AU - Luder, Anthony
AU - Blau, Hannah
AU - Alkrinawi, Soliman
AU - Aviram, Micha
AU - Ben-Ami, Marta
AU - Rotschild, Moshe
AU - Bentur, Lea
AU - Shoseyov, David
AU - Cohen-Cymberknoh, Malena
AU - Kerem, Eitan
AU - Avital, Avraham
AU - Springer, Chaim
AU - Hevroni, Avigdor
AU - Dabbah, Husein
AU - Elizur, Arnon
AU - Picard, Elie
AU - Goldberg, Shmuel
AU - Rivlin, Joseph
AU - Livnat, Galit
AU - Lavie, Moran
AU - Alias, Nael
AU - Soferman, Ruth
AU - Olbrich, Heike
AU - Raidt, Johanna
AU - Wallmeier, Julia
AU - Werner, Claudius
AU - Loges, Niki T.
AU - Omran, Heymut
N1 - Publisher Copyright:
© 2016 Amirav I et al.
PY - 2016
Y1 - 2016
N2 - Rationale: Primary ciliary dyskinesia (PCD) is under diagnosed and underestimated. Most clinical research has used some form of questionnaires to capture data but none has been critically evaluated particularly with respect to its end-user feasibility and utility. Objective: To critically appraise a clinical data collection questionnaire for PCD used in a large national PCD consortium in order to apply conclusions in future PCD research. Methods: We describe the development, validation and revision process of a clinical questionnaire for PCD and its evaluation during a national clinical PCD study with respect to data collection and analysis, initial completion rates and user feedback. Results: 14 centers participating in the consortium successfully completed the revised version of the questionnaire for 173 patients with various completion rates for various items. While content and internal consistency analysis demonstrated validity, there were methodological deficiencies impacting completion rates and end-user utility. These deficiencies were addressed resulting in a more valid questionnaire. Conclusions: Our experience may be useful for future clinical research in PCD. Based on the feedback collected on the questionnaire through analysis of completion rates, judgmental analysis of the content, and feedback from experts and end users, we suggest a practicable framework for development of similar tools for various future PCD research.
AB - Rationale: Primary ciliary dyskinesia (PCD) is under diagnosed and underestimated. Most clinical research has used some form of questionnaires to capture data but none has been critically evaluated particularly with respect to its end-user feasibility and utility. Objective: To critically appraise a clinical data collection questionnaire for PCD used in a large national PCD consortium in order to apply conclusions in future PCD research. Methods: We describe the development, validation and revision process of a clinical questionnaire for PCD and its evaluation during a national clinical PCD study with respect to data collection and analysis, initial completion rates and user feedback. Results: 14 centers participating in the consortium successfully completed the revised version of the questionnaire for 173 patients with various completion rates for various items. While content and internal consistency analysis demonstrated validity, there were methodological deficiencies impacting completion rates and end-user utility. These deficiencies were addressed resulting in a more valid questionnaire. Conclusions: Our experience may be useful for future clinical research in PCD. Based on the feedback collected on the questionnaire through analysis of completion rates, judgmental analysis of the content, and feedback from experts and end users, we suggest a practicable framework for development of similar tools for various future PCD research.
UR - http://www.scopus.com/inward/record.url?scp=85010932228&partnerID=8YFLogxK
U2 - 10.12688/F1000RESEARCH.9323.1
DO - 10.12688/F1000RESEARCH.9323.1
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:85010932228
SN - 2046-1402
VL - 5
JO - F1000Research
JF - F1000Research
M1 - 2031
ER -